期刊文献+

非小细胞肺癌组织中E1AF、MMP-7、uPA的表达及其临床意义

Expressions and clinical significances of E1AF,MMP-7 and uPA in non-small cell lung cancer
原文传递
导出
摘要 目的检测非小细胞肺癌(NSCLC)组织中E1A因子(E1AF)、基质溶解素(MMP-7)、尿激酶纤溶酶原激活物(uPA)的表达及其与临床病理特征之间的关系。方法采用免疫组织化学技术检测56例NSCLC组织及其癌旁配对正常肺组织中MMP-7、uPA蛋白的表达,采用RT-PCR方法检测E1AFmRNA的表达。结果与癌旁配对正常肺组织相比,NSCLC中E1AFmRNA、MMP-7和uPA表达明显升高(P<0.01),E1AF表达与MMP-7及uPA的表达分别呈正相关(P<0.05);MMP-7与uPA表达无显著相关性(P>0.05);E1AF、MMP-7、uPA表达均与组织类型无关,E1AF、MMP-7与分化程度有关,uPA与肿瘤大小有关,三者均与TNM合并分期和淋巴结转移密切相关(P<0.05)。结论 E1AF、MMP-7和uPA在NSCLC组织中的表达与肿瘤的浸润、转移有关,E1AF可能在转录水平上调控MMP-7和uPA的表达,E1AF基因可作为肺癌基因诊断和治疗的新靶点,联合检测有助于判断患者的预后。 Objective To detect the expressions of early region 1A factor (EIAF), matrilysin (MMP-7) and uroki- nase-type plasminogen activator (uPA) in non-small cell lung cancer tissues (NSCLC), and to study their relationships with the clinical and pathological features. Methods The expressions of MMP-7 and uPA in 56 cases of NSCLC tis- sues and paired normal lung tissues were detected by SP immunohistochemical staining and examination on the expres- sion of E1AFmRNA by RT-PCR assay. Results The expressions of E1AFmRNA, MMP-7 and uPA in the tissues of NSCLC were significantly higher than those in the paired normal lung tissues (P 〈 0.01 ). There were also positive cor- relations between the expressions of E1AF and MMP-7, uPA in NSCLC(P 〈0.05). The expressions of MMP-7 and uPA had no significant correlation( P 〉 0.05 ). The expression levels of E1AF, MMP-7 and uPA were closely related with clinical merger stages and lymph node metastasis, but had no relationship with histological classification. E1AF and MMP-7 were closely related with differentiations, and uPA was closely related with tumor size ( P 〈 0. 05 ). Conclusion Abnormal expressions of EIAF, MMP-7 and uPA may play important roles in the infiltration and metasta- sis in NSCLC; E1AF may regulate the expressions of MMP-7 and uPA at transcription level; E1AF gene can be used as a new target gene for diagnosis and treatment of lung cancer; the united detection of E1AF, MMP-7 and uPA expres- sions mav be heloful to evaluate the nrognosis of NSCLC.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第7期109-113,共5页 Journal of Shandong University:Health Sciences
关键词 因子E1A 基质溶解因子 尿纤溶酶原激活物 非小细胞肺 免疫组织化学 Factor EIA Matrilysin Urinary plasminogen activator Carcinoma, non-small-cell lung Immunohisto-chemistry
  • 相关文献

参考文献11

  • 1Higashino F,Yoshida K,Noumi T. Ets-related protein E1A-F caa activate three different matrix metalloproteinase gene promoters[J].Oncogene,1995,(07):1461-1463.
  • 2Shindoh M,Higashino F,Kohgo T. EIAF,an ets-oncogene family transcription factor[J].Cancer Letters,2004,(01):1-8.doi:10.1016/j.canlet.2004.07.020.
  • 3Tseng J E,Kemp B L,Khuri F R. Loss of Fhit is frequent in stage Ⅰ non-small cell lung cancer and in the lungs of chronic smokers[J].Cancer Research,1999,(19):4798-4803.
  • 4Higashino F,Yoshida K,Fujinaga Y. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein:a new human member of the ets oncogene family[J].Nucleic Acids Research,1993,(03):547-553.doi:10.1093/nar/21.3.547.
  • 5Zhu X,Jiang J,Shen H. Elevated beta I,4-galaetosyltransferase I in highly metastatic human lung cancer cells.Identification of EIAF as important transcription activator[J].Journal of Biological Chemistry,2005,(13):12503-12516.doi:10.1007/s10552-008-9292-9.
  • 6Hollenhorst P C,Jones D A,Graves B J. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors[J].Nucleic Acids Research,2004,(18):5693-5702.doi:10.1093/nar/gkh906.
  • 7Kaya M,Yoshida K,Higashino F. A single ets-related transcription factor,El AF,confers invasive phenotype on human cancer cells[J].Oncogene,1996,(02):221-227.
  • 8Yamamoto H,Horiuchi S,Adachi Y. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over expression of matrilysin in human gastric cancer[J].Carcinogenesis,2004,(03):325-332.doi:10.1093/carcin/bgh270.
  • 9Maeta N,Osaki M,Shomori K. CYR61 down regulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma[J].Oncology(Basel),2007,(1/2):118-126.
  • 10Czekay R P,Loskutoff D J. Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism[J].Journal of Cellular Physiology,2009,(03):655-663.doi:10.1002/jcp.21806.

二级参考文献31

  • 1Kindzelskii AL,Amhad I, Keller D, et al. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator. Histochem Cell Biol, 2004,121(4):299-310.
  • 2Hall CL, Tsan R, Mugnai G, et al. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor(HGF) induction of urokinase-type plasminogen activator(uPA). Prostate, 2004, 59(2):167-76.
  • 3Kobayashi H, Suzuki M, Kanayama N, et al. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int J Cancer, 2002,
  • 4Netzer S, Leenders F, Dumont P, et al. Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription. Trans Res,2002, 11 (2):123-31.
  • 5Tanaka Y, Kobayashi H, Suzuki M, et al. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem,2004,279(10):8 567-76.
  • 6Giusti C, Desruisseau S, Ma L, et al. Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells. Int J Cancer,2003,105(6):769-78.
  • 7Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase-type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem,
  • 8Tran H, Maurer F, Nagamine Y. Stabilization of urokinase and urokinase receptor mRNA by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activited protein kinase-activited protein kinase 2. Mol Cell Biol,2003,23(20):7 177-88.
  • 9Puricelli L, Proiettii CJ, Labriola L, et al. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. Int J Ca
  • 10Jo M, Thomas KS, Wu L, et al. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-dependent effects on cell signaling. J Biol Chem,2003,278(47):46 692-8.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部